Your compliance team wants clear guidance. The regulations aren't there yet. So what do you do?

For healthcare organizations managing translated member communications, clinical content, and patient-facing materials, the absence of clear AI rules isn't a reason to wait—it's a reason to get ahead. Because when the standards do arrive, they'll reflect what the best-run programs are already doing. “Practice becomes policy” is a pattern the industry has followed before and AI in translation is next.

Watch this session with Renato Beninatto, Co-Founder, Nimdzi and David Paré, GM of Life Sciences, Smartling—two of the industry’s most experienced voices—to learn what responsible AI translation governance looks like today, what the regulatory signals are telling us, and how to build a program you can defend to any auditor and any administration.


What we cover:
  • Why AI translation practices today will become the compliance standards tomorrow — and what that means for your program
  • How to scale managed care translation without scaling headcount
  • How to manage PII/PHI, HIPAA compliance
  • How to process high-volume content like grievance letters and EOBs
  • What FDA, ISO, and the current regulatory landscape are signaling about where rules are headed